Document is current
Any future updates will be listed below
-
Authors
Lobel, Joseph H. https://orcid.org/0000-0001-5986-7280
Ingolia, Nicholas T. https://orcid.org/0000-0002-3395-1545
- License Information
-
More Information
Article History
Received: 8 May 2024
Accepted: 19 March 2025
First Online: 23 April 2025
Competing interests
: N.T.I. holds equity in and serves as a scientific advisor to Tevard Biosciences, and holds equity in Velia Therapeutics. J.H.L. declares no competing interests.
